Prot #YO39609: A Phase Ib/II, Open-Label, Multicenter, Randomized, Umbrella Study Evaluating the Efficacy and Safety of Multiple Immunotherapy-Based Treatment Combinations in Patients with Locally Advanced Unresectable or Metastatic Gastric or Gastroesoph

Project: Research project

Project Details

StatusActive
Effective start/end date4/2/21 → 4/2/24

Funding

  • Covance Inc. (Prot #YO39609)
  • Genentech, Inc. and Hoffmann-La Roche Inc. (Prot #YO39609)